Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study Commentaries: Ongoing trial shows Pfizer Covid-19 vaccine remains highly effective after six months – CNN AND Coronavirus: Pfizer jab ‘stopping 91% of cases in first six months’ […]
The post [Press release – not published yet] Pfizer/BioNTech vaccine is 91% effective for at least 6 months appeared first on Links Medicus.
Why you can’t compare Covid-19 vaccines – Vox
The post Video: Why you can’t compare Covid-19 vaccines appeared first on Links Medicus.
“Vaccine Passport” Certification — Policy and Ethical Considerations – New England Journal of Medicine Related: Covid-19 vaccine passports will harm sustainable development – The BMJ Opinion AND Covid-19 vaccine passports and vaccine hesitancy: freedom or control? – The BMJ Opinion AND Vaccine certificates: does the end justify the means? – The Lancet Microbe AND Interim […]
The post Opinion | “Vaccine Passport” Certification — Policy and Ethical Considerations appeared first on Links Medicus.
Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials – The Lancet Diabetes & Endocrinology Commentaries: Vitamin D to prevent acute respiratory infections – The Lancet Diabetes & Endocrinology AND
The post M-A: Vitamin D supplementation to prevent acute respiratory infections appeared first on Links Medicus.
Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study – The BMJ Commentary on Twitter Follow-up of nearly 48,000 hospitalized patients with covid-19 shows a high rate of readmission, death, and multi-organ disease (heart, diabetes, kidney, lung) compared with matched controls https://t.co/dzxVYdugz2 @bmj_latest pic.twitter.com/hWBn5w2XQf — Eric Topol (@EricTopol) April 1, 2021 […]
The post Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study appeared first on Links Medicus.
Vaccine certificates: does the end justify the means? – The Lancet Microbe Related: Covid-19 vaccine passports will harm sustainable development – The BMJ Opinion AND Covid-19 vaccine passports and vaccine hesitancy: freedom or control? – The BMJ Opinion AND “Vaccine Passport” Certification — Policy and Ethical Considerations – New England Journal of Medicine AND Interim […]
The post Editorial | Vaccine certificates: does the end justify the means? appeared first on Links Medicus.
Press release: Pfizer-BioNTech Announce Positive Topline Results Of Pivotal Covid-19 Vaccine Study In Adolescents Commentaries: The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents – The New York Times AND Covid: Children ‘well protected by Pfizer vaccine’ – BBC AND Pfizer Says COVID-19 Vaccine Shows ‘100% Efficacy’ In Adolescents – NPR AND Pfizer […]
The post [Press release – not published yet] Pfizer-BioNTech vaccine 100% effective against Covid-19 in adolescents appeared first on Links Medicus.
5 things you should know about variants – GatesNotes Commentary on Twitter Here are five things you should know if you want to understand how variants are (and aren’t) complicating the pandemic. https://t.co/rANiDcZynJ — Bill Gates (@BillGates) March 31, 2021
The post Bill Gates: 5 things you should know about variants appeared first on Links Medicus.
Sinopharm, Sinovac COVID-19 vaccine data show efficacy: WHO – Reuters Commentary on Twitter WHO decision on Sinopharm & Sinovac vaccines coming in the next few weeks: signal from WHO at a press briefing that the decision may be positive https://t.co/HcbZnJ7WDE — Hilda Bastian, PhD (@hildabast) March 31, 2021
The post WHO: Sinopharm, Sinovac COVID-19 vaccine data show efficacy appeared first on Links Medicus.
AstraZeneca COVID vaccine 70% effective vs B117 variant – CIDRAP Original study: Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial – The Lancet Commentary on Twitter (thread – Click for more) ASYMPTOMATIC & SYMPTOMATIC Efficacy of Oxford-AstraZeneca #COVID19 vaccine versus #B117 […]
The post AstraZeneca COVID vaccine 70% effective vs. B117 variant appeared first on Links Medicus.